|
|
|
|
|
COST-UTILITY ANALYSIS OF PREEMPTIVE LIVING-RELATED KIDNEY TRANSPLANTATION COMPARE TO NONPREEMPTIVE STRATEGIES IN THAILAND |
2564 |
# |
|
|
|
|
|
Cost-Utility Analysis of Sacubitril-Valsartan Compared with Enalapril Treatment in Patients with Acute Decompensated Heart Failure in Thailand |
2564 |
# |
|
|
|
|
|
Cost-Utility Analysis of Transcatheter Aortic Valve Implantation versus Surgery in High-Risk Severe Aortic Stenosis Patients in Thailand |
2565 |
# |
|
|
|
|
|
Cost-Utility Analysis of Vasoconstrictors Plus Albumin in the Treatment of Thai Patients with Type 1 Hepatorenal Syndrome |
2564 |
# |
|
|
|
|
|
Cost-utility and budget impact analysis of tocilizumab for the treatment of refractory systemic juvenile idiopathic arthritis in Thailand |
2563 |
# |
|
|
|
|
|
Cost–Utility Analysis of Dapagliflozin as an Add-on to Standard of Care for Patients with Chronic Kidney Disease in Thailand |
2565 |
# |
|
|
|
|
|
Cotrimoxazole prophylaxis decreases tuberculosis risk among Asian patients with HIV |
2562 |
# |
|
|
|
|
|
Country Level Diversity of the HIV-1 Pandemic between 1990 and 2015 |
2564 |
# |
|
|
|
|
|
Covalently linked dengue virus envelope glycoprotein dimers reduce exposure of the immunodominant fusion loop epitope |
2560 |
# |
|
|
|
|
|
COVID-19 and gynecological cancers: Asia and Oceania Federation of Obstetrics and Gynecology oncology committee opinion |
2564 |
# |
|
|
|
|
|
COVID-19 and older people in Asia: Asian Working Group for Sarcopenia calls to actions |
2563 |
# |
|
|
|
|
|
COVID-19 Breakthrough Infection after Inactivated Vaccine Induced Robust Antibody Responses and Cross-Neutralization of SARS-CoV-2 Variants, but Less Immunity against Omicron |
2565 |
# |
|
|
|
|
|
COVID-19 in dermatology practice: getting back on track |
2563 |
# |
|
|
|
|
|
COVID-19 Pandemic and Burden of Non-Communicable Diseases: An Ecological Study on Data of 185 Countries |
2563 |
# |
|
|
|
|
|
COVID-19 vaccine boosters in the Asia-Pacific region in the context of Omicron |
2565 |
# |
|
|
|
|
|
COVID-19-associated myositis may be dermatomyositis |
2564 |
# |
|
|
|
|
|
COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics |
2563 |
# |
|
|
|
|
|
Cranial dural arteriovenous fistulas: Can noninvasive imaging predict angiographic findings? |
2561 |
# |
|
|
|
|
|
Cranial dural arteriovenous shunts: An evaluation of the outcome |
2561 |
# |
|
|
|
|
|
Creation of an integrated outcome database for pediatric anesthesia |
2559 |
# |
|
|
|
|
|
Cribriform morular variant of papillary thyroid carcinoma: Clinical and cytomorphological features on fine-needle aspiration |
2556 |
# |
|
|
|
|
|
Crisis Team Management in a Scarce Resource Setting: Angkor Hospital for Children in Siem Reap, Cambodia. |
2560 |
# |
|
|
|
|
|
CRISP: a deep learning architecture for GC × GC-TOFMS contour ROI identification, simulation and analysis in imaging metabolomics |
2565 |
# |
|
|
|
|
|
CRISPR/Cas9 Ribonucleoprotein Complex-Mediated Efficient B2M Knockout in Human Induced Pluripotent Stem Cells (iPSCs) |
2565 |
# |
|
|
|
|
|
CRISPR/Cas9-Mediated GFP Reporter Knock-in in K562 and Raji Cell Lines for Tracking Immune Cell Killing Assay |
2564 |
# |
|
|
|
|
|
Critical Appraisal on the Quality of Reporting on Safety and Efficacy of Transcarotid Artery Stenting With Flow Reversal |
2563 |
# |
|
|
|
|
|
Critical Care Management of Patients with COVID-19: Early Experience in Thailand |
2563 |
# |
|
|
|
|
|
Critical Care Resource Utilization and Outcomes of Children with Moderate Traumatic Brain Injury |
2560 |
# |
|
|
|
|
|
CRITICAL ILLNESS-RELATED CORTICOSTEROID INSUFFICIENCY: WHICH INDEX IS THE BEST DIAGNOSTIC TOOL FOR THAI SEPTIC SHOCK PATIENTS? |
2552 |
# |
|
|
|
|
|
Critical Role of the PA-X C-Terminal Domain of Influenza A Virus in Its Subcellular Localization and Shutoff Activity |
2559 |
# |